Hall A, Booth 137
La Jolla, California, United States
AccuDava is focused on developing novel glycan-based methods for cancer treatments. Our proprietary tests to predict patients response to chemotherapy have been tested on ovarian and non-small cell lung cancers. AccuDava has also introduced a glycoenzyme therapeutic method to overcome chemoresistance in cancer patients treated with platinum drugs.
Latest Announcements
Congratulations to the Buzz of BIO winners!
Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and…
Voting for the Buzz of BIO contest is now closed. Winners will be announced on March 24. The contest provides visibility for companies looking to…